Navigation Links
Fort Floppy

ProductsFort Floppy
Company Boston Scientific Corporation
Item Fort Floppy
Features 
  • High performance, full spring coil, stainless steel guide wire with radiopaque markers designed to increase accuracy of measuring lesion length.
  • Front line performance with 1:1 torque and excellent track.
  • Flexible, low profile marker system.
  • Two convenient 5mm markers with 15mm spacing for multiple measurements.
  • Enhanced tip radiopacity over the Trooper Guide Wire.
  • Radiopaque markers aid in precise lesion assessment and accurate stent selection.
    • Description Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. Needle and Gouge Spud Set
    2. Replacement Needle Tip
    3. Needle Knife, Straight, Full Handle, Non-Reflective, 0.74 mm Width
    4. Retrobulbar Needle, 23 g. Atkinson style bevel.
    5. Peribulbar Needle, 23 g. Atkinson style bevel.
    6. Peribulbar Needle, 25 g. Atkinson style bevel.
    7. Retrobulbar Needle, 25 g. Atkinson style bevel.
    8. Anterior Chamber Needle, 20 g. Angled
    9. Anterior Chamber Needle, 23 g. Angled
    10. Anterior Chamber Needle, 25 g. Angled
    11. Anterior Chamber Needle, 30 g. Angled
    TAG: Fort Floppy
    Other Medicine News:Health News:China Display Technologies, Inc. to Present at Roth Conference 2Health News:China Display Technologies, Inc. to Present at Roth Conference 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 4Health News:Researchers discover new way to reverse poor circulation and heal wounds 2Health News:Researchers discover new way to reverse poor circulation and heal wounds 3Health News:Researchers discover new way to reverse poor circulation and heal wounds 4Health News:Southern Research Institute Names Blaine Knight Vice President of Drug Discovery 2Health News:DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 2Health News:DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 3Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 2Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 3Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 4Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 5Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 6Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 7Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 8Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 9Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 10Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 11Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 12Health News:Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine 13
    Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 1DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 2DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 4DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8